These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7866377)

  • 21. The economic cost of low back pain in Sweden in 2001.
    Ekman M; Johnell O; Lidgren L
    Acta Orthop; 2005 Apr; 76(2):275-84. PubMed ID: 16097556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementary and Alternative Medicine Use by Normal Weight, Overweight, and Obese Patients with Arthritis or Other Musculoskeletal Diseases.
    Mbizo J; Okafor A; Sutton MA; Burkhart EN; Stone LM
    J Altern Complement Med; 2016 Mar; 22(3):227-36. PubMed ID: 26938367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of low back pain cost of illness studies in the United States and internationally.
    Dagenais S; Caro J; Haldeman S
    Spine J; 2008; 8(1):8-20. PubMed ID: 18164449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of major musculoskeletal conditions.
    Woolf AD; Pfleger B
    Bull World Health Organ; 2003; 81(9):646-56. PubMed ID: 14710506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keeping our patients at work: implications for the management of those with rheumatoid arthritis and musculoskeletal conditions.
    Frank AO; Chamberlain MA
    Rheumatology (Oxford); 2001 Nov; 40(11):1201-5. PubMed ID: 11709602
    [No Abstract]   [Full Text] [Related]  

  • 26. Improving work participation for adults with musculoskeletal conditions.
    Wilkie R; Pransky G
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):733-42. PubMed ID: 23218435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burden of disability due to musculoskeletal (MSK) disorders.
    March L; Smith EU; Hoy DG; Cross MJ; Sanchez-Riera L; Blyth F; Buchbinder R; Vos T; Woolf AD
    Best Pract Res Clin Rheumatol; 2014 Jun; 28(3):353-66. PubMed ID: 25481420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of common low back pain and lumbar radiculopathy in rheumatologic consultation in Lomé.
    Fianyo E; Oniankitan O; Tagbor Komi C; Kakpovi K; Houzou P; Koffi-Tessio Viwalé ES; Mijiyawa M
    Tunis Med; 2017 Mar; 95(3):168-171. PubMed ID: 29446809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost of obesity: the US perspective.
    Wolf AM; Colditz GA
    Pharmacoeconomics; 1994; 5(Suppl 1):34-7. PubMed ID: 10147247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic implications of cyclooxygenase-2-specific inhibitors.
    Peloso PM; Scheiman JM
    Am J Med; 2001 Feb; 110 Suppl 3A():50S-4S. PubMed ID: 11173051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
    Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
    J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.
    Furneri G; Mantovani LG; Belisari A; Mosca M; Cristiani M; Bellelli S; Cortesi PA; Turchetti G
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S72-84. PubMed ID: 23072761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined impact of concomitant arthritis and back problems on health status: results from a nationally representative health survey.
    Bollegala D; Perruccio AV; Badley EM
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1584-91. PubMed ID: 22034120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre.
    Aggarwal A; Chandran S; Misra R
    Natl Med J India; 2006; 19(4):187-91. PubMed ID: 17100104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis.
    Her M; Kavanaugh A
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S107-11. PubMed ID: 23078839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
    Lundkvist J; Kastäng F; Kobelt G
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter cost-of-illness study on rheumatoid arthritis in Italy.
    Leardini G; Salaffi F; Montanelli R; Gerzeli S; Canesi B
    Clin Exp Rheumatol; 2002; 20(4):505-15. PubMed ID: 12175106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Musculoskeletal medicine--strategies towards a "good musculoskeletal consultation"].
    Vulfsons S
    Harefuah; 2011 Mar; 150(3):237-9, 305, 304. PubMed ID: 21574355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
    Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
    Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Musculoskeletal disorders and the Global Burden of Disease study.
    Storheim K; Zwart JA
    Ann Rheum Dis; 2014 Jun; 73(6):949-50. PubMed ID: 24790065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.